NVO
Novo Nordisk A/SNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$194.70B
P/E Ratio
10.32
EPS
$4.26
Beta
0.35
52W High
$74.76
52W Low
$34.58
50-Day MA
$42.26
200-Day MA
$48.46
Dividend Yield
4.10%
Profit Margin
37.20%
Forward P/E
12.87
PEG Ratio
3.19
About Novo Nordisk A/S
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Fundamentals
| Revenue (TTM) | $327.80B |
| Gross Profit (TTM) | $272.72B |
| EBITDA | $173.88B |
| Operating Margin | 61.60% |
| Return on Equity | 71.40% |
| Return on Assets | 19.30% |
| Revenue/Share (TTM) | $73.77 |
| Book Value | $7.05 |
| Price-to-Book | 6.17 |
| Price-to-Sales (TTM) | 0.59 |
| EV/Revenue | 4.198 |
| EV/EBITDA | 7.65 |
| Quarterly Earnings Growth (YoY) | 67.10% |
| Quarterly Revenue Growth (YoY) | 24.00% |
| Shares Outstanding | $3.35B |
| Float | $3.19B |
| % Insiders | 0.01% |
| % Institutions | 9.84% |
Historical Volatility
HV 10-Day
47.34%
HV 20-Day
36.85%
HV 30-Day
34.14%
HV 60-Day
33.98%
HV Rank
18.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($47.27 target)
1
Strong Buy4
Buy9
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026